Anxietydisorders represent one of the most widespread mental health challenges globally, yet access to traditional therapeutic interventions remains constrained, particularly in resource-limited settings. This study evaluated the effectiveness of anAI-powered chatbot, developed using ChatGPT, in managinganxietysymptoms through evidence-based cognitive-behavioral therapy (CBT) techniques ...
Anxietydisorders are among the most common mental health conditions, affecting millions worldwide. However, access to therapy remains a challenge due to high costs, social stigma, and a shortage of mental health providers (Frontiers in Public Health, 2024) (8). Artificial intelligence (AI) can help bridge this gap by offering 24/7 mental health support through chatbots,
Tools such asAI-driven chatbots, mobile apps, and LLMs have demonstrated efficacy in reducing symptoms ofanxietyand depression, improving user engagement and mental health outcomes.
As a result, this study aims to establish the efficacy ofAI-enabled environments in addressing the existing challenges in managinganxietydisorders, reducing reliance on medication, and investigating the potential advantages, issues, and opportunities of integratingAI-assistedhealthcare foranxietydisorders and enabling personalized therapy.
Adults with cystic fibrosis (AWCF) have higher rates of depression andanxietythan comparable community members. This multisite randomized waitlist-controlled trial tested the efficacy of "Coping and Learning to Manage Stress withCF" (CALM), a 6-session+booster telehealth intervention to improve depression andanxietysymptoms (primary outcomes) and perceived stress, coping self-efficacy ...
